Literature DB >> 23302321

[Molecular pathology of lung cancer: key to personalized medicine].

Liang Cheng1, Yuan Li, Shao-bo Zhang, Xiao-dong Teng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23302321     DOI： 10.3760/cma.j.issn.0529-5807.2012.10.019

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN： 0529-5807


× No keyword cloud information.
  3 in total

1.  Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations.

Authors:  Ilenia Chatziandreou; Panagiota Tsioli; Stratigoula Sakellariou; Ioanna Mourkioti; Ioanna Giannopoulou; Georgia Levidou; Penelope Korkolopoulou; Efstratios Patsouris; Angelica A Saetta
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 2.  CD47 as a promising therapeutic target in oncology.

Authors:  Hai Zhao; Shuangshuang Song; Junwei Ma; Zhiyong Yan; Hongwei Xie; Ying Feng; Shusheng Che
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

3.  Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium).

Authors:  Sun Min Lim; Hye Ryun Kim; Eun Kyung Cho; Young Joo Min; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Byoung Chul Cho; Ji-Hyun Lee; Hye Cheol Jeong; Eun Kyung Kim; Joo-Hang Kim
Journal:  Oncotarget       Date:  2016-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.